Measures IgM antibodies directed against cardiolipin, a phospholipid-associated antigen.
Used to support the evaluation of antiphospholipid syndrome (APS), particularly in people with unexplained blood clots, recurrent pregnancy complications, or systemic autoimmune disease such as lupus.